OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Johnson & Johnson/  US4781601046  /

IEX
12/7/2021  9:59:58 PM Chg. +0.47 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
163.39USD +0.29% 221,210
Turnover: 36.13 mill.		 -Bid Size: - -Ask Size: - 430.06 bill.USD 2.44% 29.22
GlobeNewswire 1:30 PM Pensa Hires Kroger Veteran Mark Abernathy As Retail Market Lead
TeleTrader 12/5 Walensky: FDA may streamline jab approval
TeleTrader 11/29 J&J to evaluate its vaccine against Omicron variant
TeleTrader 11/26 J&J testing vaccine against new strain
TeleTrader 11/24 Canada gives full approval to J&J COVID vaccine
TeleTrader 11/22 EMA evaluating J&J's booster shot application
TeleTrader 11/16 Japan to ease quarantine rules for J&J recipients - report
TeleTrader 11/12 J&J confirms plans to split into two companies
TeleTrader 11/12 Report: J&J planning to split into two companies
TeleTrader 11/10 US to donate J&J COVID vaccines to conflict zones - report
TeleTrader 11/5 Emergent shares dive after US govt. cancels deal
TeleTrader 10/20 FDA approves Moderna, J&J booster COVID shot
GlobeNewswire 10/20 Pensa Hires Tim Whiting As Head of Marketing
TeleTrader 10/19 J&J's Q3 revenue at $23.3 billion, up by 10.7% YoY
TeleTrader 10/15 FDA panel recommends J&J booster shot
TeleTrader 10/13 'Mixing and matching' COVID vaccines effective - study
TeleTrader 10/13 FDA staff: There could be benefits to J&J booster shot
TeleTrader 10/13 mRNA booster works better than J&J's 2nd shot - report
TeleTrader 10/8 CDC to discuss Moderna, J&J boosters in 2 weeks
TeleTrader 10/5 J&J files for booster shot approval in US
TeleTrader 10/4 J&J to ask for booster shot authorization this week - report
TeleTrader 10/2 Trump says he got the Pfizer vaccine
TeleTrader 10/1 EMA finds additional risk in J&J COVID vaccine
TeleTrader 9/24 CDC to evaluate data on J&J, Moderna boosters
TeleTrader 9/21 J&J COVID booster jab raises antibodies 12-fold - study